skip to Main Content
Pakistani American Pharmacist Association
Click This Button For Register

Speaker Fawad Piracha Pharm.D 9:00 am
Topic: COVID-19 Treatment with Monoclonal Antibodies (mAbs)
Learning Objectives:
1. Discuss the effectiveness of monoclonal antibody treatment for eligible patients
2. Explain, Expanded eligibility criteria
3. Outline Strategies to increase access
4. Discuss Case studies

Speaker Samar Shamsi Pharm.D 10:00 am
Topic: Psychiatric and Psychosocial Disorders in Pediatrics
Learning Objectives:
• Describe the different types of disorders
• Describe the characteristics of the various disorders
• Recognize tools for mental health screening in pediatric patients
• List interventions to prevent suicide and violent behavior
• Identifying pharmacological and non-pharmacological ways to treat the disorders

Speaker Zachary Piracha Pharm.D 11:00 am
Topic: Overview of Major Depression Disorder (MDD)
Learning Objectives:
• Define Diagnostic Criteria and risk factors for developing a depressive disorder
• Characterize mechanism of action, adverse events, drug interactions, and
warnings/precautions for the use of medications used for the treatment of depression
• Evaluate treatment guidelines and clinical trials regarding treatment of a major depressive
disorder
• Discuss pharmacist’s role in providing patient care and education to patients with major
depressive disorder

Speaker James Schiffer, Attorney at Law, and Carlos Aquino 1:00 pm – 4:00 pm
“A Review of Recent DEA Pharmacy Investigations and Related Resolution of Such
Settlements”
Learning Objectives:
At the completion of this activity, the participant will be able to:
1. – Identify the aspects of the Controlled Substances Act which require the registrant
(pharmacy owner/manager) to maintain complete and accurate records of controlled
substances, and the enforcement action which the DEA takes in breaches of such record
keeping requirements.
2. Identify the various DEA Red Flag Rules which help guide pharmacists in decision
making in dispensing controlled drugs.
3. Identify the requirements of the Controlled Substance Act and related rules and
regulations regarding maintaining adequate security in the premises where the pharmacy
is located.
4. Identify the responsibility of the pharmacist/pharmacy owner to report controlled
substances shortages to the Drug Enforcement Administration and understand the
penalties for failure to timely comply with such responsibility.
5. Identify the wholesalers/distributors responsibility under the Controlled Substance Act to
monitor pharmacy purchases of controlled substances and to follow the “Know your
Customer” DEA protocol.

Back To Top